Agilent Technologies (NYSE:A) Releases Q1 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its first quarter earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $1.25-1.28 for the period, compared to the consensus estimate of $1.38. The company issued revenue guidance of $1.65-1.68 billion, compared to the consensus revenue estimate of $1.70 billion. Agilent Technologies also updated its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Trading Down 0.1 %

Shares of A stock opened at $134.35 on Wednesday. Agilent Technologies has a 12 month low of $124.10 and a 12 month high of $155.35. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. The business’s 50 day moving average is $137.74 and its two-hundred day moving average is $137.43. The company has a market cap of $38.60 billion, a PE ratio of 27.87, a price-to-earnings-growth ratio of 5.89 and a beta of 1.07.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be paid a $0.248 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. Agilent Technologies’s dividend payout ratio (DPR) is presently 19.50%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on A. Citigroup raised their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. StockNews.com downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. Evercore ISI raised their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Bank of America raised their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Sanford C. Bernstein lowered their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Hold” and an average price target of $144.07.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.